Genexine and KGbio received the first market approval for novel long-acting Erythropoietin, Efepoetin alfa, from The Indonesian Food and Drug Authority (BPOM)
MSN's Generic Losartan Potassium Receives Approval in the U.S.
Enforcement Report - Week of July 12, 2023
Drug firm Granules India on Monday said it has received approval from the US health regulator to market a generic product to treat high blood pressure. The company has received approval from the US Food & Drug Administration (USFDA) to market Losartan Potassium tablets in strengths of 25 mg, 50 mg, and 100 mg, Granules India said in a regulatory filing.
Enforcement Report - Week of July 6, 2022
Strides Pharma Inc is recalling over six lakh bottles of blood pressure lowering drug Losartan Potassium tablets in the US market in multiple strengths due to deviation from standard manufacturing norms, according to a USFDA report.
Enforcement Report - Week of June 8, 2022
Enforcement Report - Week Of June 01, 2022
Enforcement Report - Week of May 11, 2022